.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer in 2014 for a mass...
.On the heels of a phase 3 win that fell short to make an impression on entrepreneurs, Ironwood Phar...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is actually having a ball after a...
.Invite to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings an...
.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...
.AbbVie has actually come back to the resource of its own antipsychotic goliath Vraylar trying to fi...
.GenSight Biologics is weeks away from running out of money. Again. The biotech simply has enough ca...
.Monopar Rehabs is recovering a medication from the scrap heap of AstraZeneca's uncommon disease pip...
.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of experts w...
.After creating a gene treatment partnership along with Dyno Therapies in 2020, Roche is back for ad...